Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Fuchs

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Ophthalmic Research|January 10, 2023
Factors That Can Prolong Ocular Treatment Duration in Age-Related Macular DegenerationPeter K Kaiser, Andrea Giani, Holger Fuchs, et al.
Biopharmaceutics & Drug Disposition|September 23, 2009
Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype ratsSilke Retlich, Barbara Withopf, Andreas Greischel, et al.
Molecular Therapy. Advances|July 12, 2026
AAV-norrin gene therapy rescues retinal defects in mice with Norrie disease and oxygen-induced retinopathyAndrea E Dillinger, Herbert Jaegle, Holger Fuchs, et al.
Gels (Basel, Switzerland)|April 26, 2024
The Injection of Gels Through an Intact Annulus Maintains Biomechanical Performance without Extrusion RiskHans-Joachim Wilke, Holger Fuchs, Karin Benz, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular PK StudyLin-Zhi Chen, David Roos, Elsy Philip, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2009
A novel device for intravaginal electronic brachytherapyFrank Schneider, Holger Fuchs, Friedlieb Lorenz, et al.
Patient Safety in Surgery|November 13, 2015
Single-stage debridement and spinal fusion using PEEK cages through a posterior approach for eradication of lumbar pyogenic spondylodiscitis: a safe treatment strategy for a detrimental conditionSven K Tschöke, Holger Fuchs, Oliver Schmidt, et al.
Molecular Pharmaceutics|April 2, 2026
Injected Eye, Fellow Eye and Systemic Pharmacokinetic Modeling of Intravitreally Administered BevacizumabMaria Franz, Ravi Kumar Jairam, Guangda Ma, et al.
Journal of Neurochemistry|February 28, 2022
A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundanceYasuo Uchida, Hina Takeuchi, Ryohei Goto, et al.
Pharmaceutical Research|April 29, 2022
Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in DogsHina Takeuchi, Masayoshi Suzuki, Ryohei Goto, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Ophthalmic Research|January 10, 2023
Factors That Can Prolong Ocular Treatment Duration in Age-Related Macular DegenerationPeter K Kaiser, Andrea Giani, Holger Fuchs, et al.
Biopharmaceutics & Drug Disposition|September 23, 2009
Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype ratsSilke Retlich, Barbara Withopf, Andreas Greischel, et al.
Molecular Therapy. Advances|July 12, 2026
AAV-norrin gene therapy rescues retinal defects in mice with Norrie disease and oxygen-induced retinopathyAndrea E Dillinger, Herbert Jaegle, Holger Fuchs, et al.
Gels (Basel, Switzerland)|April 26, 2024
The Injection of Gels Through an Intact Annulus Maintains Biomechanical Performance without Extrusion RiskHans-Joachim Wilke, Holger Fuchs, Karin Benz, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular PK StudyLin-Zhi Chen, David Roos, Elsy Philip, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2009
A novel device for intravaginal electronic brachytherapyFrank Schneider, Holger Fuchs, Friedlieb Lorenz, et al.
Patient Safety in Surgery|November 13, 2015
Single-stage debridement and spinal fusion using PEEK cages through a posterior approach for eradication of lumbar pyogenic spondylodiscitis: a safe treatment strategy for a detrimental conditionSven K Tschöke, Holger Fuchs, Oliver Schmidt, et al.
Molecular Pharmaceutics|April 2, 2026
Injected Eye, Fellow Eye and Systemic Pharmacokinetic Modeling of Intravitreally Administered BevacizumabMaria Franz, Ravi Kumar Jairam, Guangda Ma, et al.
Journal of Neurochemistry|February 28, 2022
A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundanceYasuo Uchida, Hina Takeuchi, Ryohei Goto, et al.
Pharmaceutical Research|April 29, 2022
Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in DogsHina Takeuchi, Masayoshi Suzuki, Ryohei Goto, et al.
Pageof 3